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REDEFINING MEDICAL NECESSITY: A
CONSUMER-DRIVEN SOLUTION TO THE U.S.
HEALTH CARE CRISIS
Ryan Abbott, MD, JD, MTOM* & Carl Stevens, MD, MPH**
The American health care system is plagued by high costs and
poor public health outcomes, due in part to the overuse of costly
diagnostic tests and treatments. In 2009, the Institute of Medicine
estimated that unnecessary care wastes $750 billion, equivalent to
about 30 percent of health care spending. Moreover, overtreatment can
directly harm patients as a result of surgical complications, drug
toxicity, and hospital-acquired infections.
Yet while the problem of medical waste has long been recognized,
solving the problem has proven elusive. In part, this difficulty is due to
perverse economic incentives for physicians and hospitals, which still
primarily receive reimbursement on a fee-for-service basis. Providers
are financially motivated under this system to generate a higher volume
of invasive procedures independent of their likely benefits. Patients
generally lack the information needed to decline unnecessary services,
even when they wish to actively share in medical decision-making, and
a strong cultural bias pushes both patients and physicians to “do
more,” even when evidence suggests that doing more may result in
harm. In the 1990s, managed health care organizations attempted to
rein in health care waste by stringently reviewing and prospectively
denying payment for unnecessary tests and treatments, but that
experiment was a political failure. Similarly, attempts to reduce overuse
by shifting financial risk directly onto providers through capitated
payment mechanisms have had limited success. The ability of these
mechanisms to limit waste is compromised by the real or perceived
incentive to also reduce spending on appropriate care.
We propose a new conception of medical necessity that will
reduce inappropriate care by allowing informed consumers to actively
participate in decisions about their medical care. Where evidencebased guidelines are available, medical necessity should be determined
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on the basis of an objective, multi-level Matrix of Appropriateness
rather than the subjective binary decision of an insurance company’s
medical reviewer. Such Matrices have already been created by
systematically combining published evidence with expert judgment to
create clinically detailed, evidence-based, multi-level medical necessity
ratings for elective procedures based on individual patient
characteristics. In our proposed system, if a patient desires a service
proposed by a physician under clinical circumstances that receive low
medical necessity ratings, the third-party payer would offer to cover the
service but at a sliding co-payment scale imposing greater patient cost
sharing based on the service’s appropriateness. This system would
preserve patient choice while discouraging the overuse of costly
treatments that provide little marginal value, reducing medical waste
and improving the overall value of medical care.
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Americans pay far more for their health care than citizens of
other developed countries, while receiving less value.1 Despite a
recent decrease in growth rate, overall expenditures in the U.S.
health care sector approached $2.7 trillion in 2012.2 On a per capita
basis and as a percentage of gross domestic product, the United
States ranks first among the world’s nations in health spending by a
substantial margin,3 yet population-level health outcome statistics
place the United States in the middle of the pack of developing
nations, with life expectancy ranking thirty-fourth in the World
Health Organization’s most recent statistics, just above Barbados,
Colombia, and Croatia.4 Assessments of health care quality in the
United States find even more alarming results: as much as 30 percent
of U.S. health spending represents waste, paying for services that
offer no net health benefits to the recipient and often result in harm.5
Medical errors and treatment complications have risen to become
one of the nation’s leading causes of death.6 A broad range of
interventions undertaken by public and private entities to rein in
spending, reduce waste, improve quality and safety, and enhance
value have yet to yield substantial gains in costs or system
performance.7
1. Ryan Abbott, Treating the Health Care Crisis: Complementary and Alternative
Medicine for PPACA, 14 DEPAUL J. HEALTH CARE L. 35, 36 (2011); see also Barbara Starfield,
Commentary, Is US Health Really the Best in the World?, 284(4) JAMA 483 (2000).
2. CENTERS FOR MEDICARE AND MEDICAID SERVICES, NATIONAL HEALTH EXPENDITURE
PROJECTIONS 2011–2021 available at http://www.cms.gov/Research-Statistics-Data-and-Systems
/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/Proj2011PDF.pdf.
3. OECD Health Data: Economic References, OECD ILIBRARY, http://www.oecd
-ilibrary.org/social-issues-migration-health/data/oecd-health-statistics/oecd-health-data-economic
-references_data-00548-en;jsessionid=2hsy3us5g6883.x-oecd-live-01?isPartOf=/content
/datacollection/health-data-en (last visited Oct. 8, 2014); see also Jason Kane, Health Costs: How
the U.S. Compares with Other Countries, PBS NEWSHOUR THE RUNDOWN (Oct. 22, 2012,
10:30 AM), http://www.pbs.org/newshour/rundown/2012/10/health-costs-how-the-us-compareswith-other-countries.html.
4. Life Expectancy at Birth, WORLD HEALTH ORGANIZATION (2013), http://gamapserver
.who.int/gho/interactive_charts/mbd/life_expectancy/atlas.html.
5. INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES, THE HEALTHCARE
IMPERATIVE: LOWERING COSTS AND IMPROVING OUTCOMES 74 (Pierre L. Yong et al. eds.,
2010), available at http://books.nap.edu/openbook.php?record_id=12750.
6. See generally LINDA T. KOHN ET AL., TO ERR IS HUMAN: BUILDING A SAFER HEALTH
SYSTEM 26 (Nat’l Research Council ed., 2000) (stating the results of studies revealing that
medical errors are the eighth leading cause of death in the United States).
7. In 2003, health care costs grew while barriers to access increased after health plans
loosened restrictions on care in response to consumer backlash toward managed care. Cara S.
Lesser & Paul B. Ginsburg, CTR. FOR STUDYING HEALTH SYS. CHANGE, HEALTH CARE COSTS
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The root cause of overspending and underperformance in the
U.S. health care system lies in our mechanisms for paying providers
of medical services, devices, and drugs.8 The problem is twofold.
First, we rely on free-market forces to ensure value despite
fundamental structural features that defeat free-market functioning in
the sector as a whole.9 Chief among these structural features that
inhibit free-market performance is the inability of purchasers of
health services to prospectively judge the comparative effectiveness
of alternative treatment strategies, and to base management choices
on these judgments.10 This limitation applies equally, regardless of
whether the service purchaser is an individual or a third-party payer
operating under a contractual obligation to cover the costs of all
“necessary” treatments in exchange for premium payments.11
Second, our payment mechanisms shield individuals from the
financial consequences of their treatment choices, while attaching
payment to each service rendered by providers, regardless of
outcomes, incentivizing patients and physicians to maximize service
utilization.12
AND ACCESS PROBLEMS INTENSIFY: INITIAL FINDINGS FROM HSC’S RECENT SITE VISITS (2003),
available at http://www.hschange.com/CONTENT/559/559.pdf; Cara S. Lesser & Paul B.
Ginsburg, Healthcare Cost and Access Problems Intensify: Initial Findings from HSC’s Recent
Site Visits, 63 JAMA 483 (2000). Seven years later, the United States ranked low in comparison
to other nations in terms of health system performance despite having the most costly health
system in the world. KAREN DAVIS ET AL., MIRROR, MIRROR ON THE WALL—HOW THE
PERFORMANCE OF THE U.S. HEALTH CARE SYSTEM COMPARES INTERNATIONALLY 2010
UPDATE, THE COMMONWEALTH FUND (2010), available at http://www.commonwealthfund.org
/~/media/Files/Publications/Fund%20Report/2010/Jun/1400_Davis_Mirror_Mirror_on_the_wall_
2010.pdf. And in 2013, high costs and poor system performance of the health care system remain
serious issues in the United States. See generally CATHY SCHOEN ET AL., THE COMMONWEALTH
FUND, CONFRONTING COSTS—STABILIZING U.S. HEALTH SPENDING WHILE MOVING TOWARD
A
HIGH PERFORMANCE HEALTH CARE SYSTEM (2013), available at http://
www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2013/Jan/1653_Comm
ission_confronting_costs_web_FINAL.pdf.
8. See generally THE COMMONWEALTH FUND, THE PATH TO A HIGH PERFORMANCE U.S.
HEALTH SYSTEM: A 2020 VISION AND THE POLICIES TO PAVE THE WAY (2009), available at
http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2009/Feb/The
%20Path%20to%20a%20High%20Performance%20US%20Health%20System/1237_Commissio
n_path_high_perform_US_hlt_sys_WEB_rev_03052009.pdf (discussing the need to change the
way the United States delivers and pays for health care to reduce health care costs and increase
access).
9. See Paul Krugman, Op-Ed., Why Markets Can’t Cure Healthcare, N.Y. TIMES
(July 25, 2009, 5:07 PM), http://krugman.blogs.nytimes.com/2009/07/25/why-markets-cant-cure
-healthcare/.
10. See id.
11. See id.
12. See, e.g., Toby Gosden et al., Capitation, Salary, Fee-for-Service and Mixed Systems of
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In contrast to most other economically advanced nations whose
citizens have elected to include medical care within a package of
social benefits defined by national statutes,13 U.S. citizens receive
medical goods and services through a complex web of legal contracts
between individuals and a broad array of public and private
entities.14 In the most common model, firms contract with
commercial third-party health insurance entities to pay for health
services, devices, and pharmaceuticals needed by their employees.15
For citizens older than sixty-five, the federally funded Medicare
program effectively contracts with individual hospitals, physicians,
and pharmacies to pay for professional services, facility costs, and
prescription medicines.16 A hybrid arrangement in which Medicare
purchases private health insurance on behalf of members represents a
smaller segment of the over sixty-five market, and creates
contractual relationships between Medicare members and third-party
health plans that mirror employee benefit coverage.17
All of the contractual relationships between health care
Payment: Effects on the Behaviour of Primary Care Physicians (Review), 3 COCHRANE
DATABASE OF SYSTEMATIC REVIEW (2000), available at onlinelibrary.wiley.com/doi
/10.1002/14651858.CD002215/pdf (evidencing that a fee-for-service payment system resulted in
primary care physicians providing, and patients using, a higher quantity of care). In addition to
direct financial incentives, providers are also motivated to provide medically unnecessary
services for defensive medical purposes. See, e.g., Daniel Kessler & Mark McClellan, Do Doctors
Practice Defensive Medicine, 111 Q. J. OF ECON. 353, 388 (1996). For example, an emergency
room physician may order a head computerized tomography (CT) scan on a patient who reports
head trauma, even in the absence of a clear medical indication. This may be because the physician
is concerned about malpractice liability, and there is little downside to the physician for ordering
the imaging. However, a CT scan and analysis by a radiologist represents a substantial medical
expense, and the test also exposes the patient to unnecessary radiation. Choosing Wisely: Imaging
Tests For Lower-Back Pain, CONSUMER REPORTS (2012), http://consumerhealthchoices.org/wpcontent/uploads/2012/06/ChooseWiselyBackPainAAFP-ER.pdf. Similarly, doctors may order
imaging to satisfy patients. If a patient with lower back pain desires an MRI in the absence of a
clear medical indication, there is again little downside to the physician for ordering such a test
and making the patient happy. Cultural norms also promote “doing more,” even when there is
evidence that doing more may be harmful. See generally OTIS WEBB BRAWLEY, HOW WE DO
HARM: A DOCTOR BREAKS RANKS ABOUT BEING SICK IN AMERICA (2011) (providing real-life
examples of various scenarios where additional procedures may harm patients).
13. Max Fisher, Here’s a Map of the Countries That Provide Universal Health Care
(America’s Still Not in It), THE ATLANTIC (June 28, 2012, 6:09 PM), http://www.theatlantic.com
/international/archive/2012/06/heres-a-map-of-the-countries-that-provide-universal-health-care
-americas-still-not-on-it/259153/.
14. William Sage, Managed Care’s Crimea: Therapeutic Benefit, and the Goals of
Administrative Process in Health Insurance, 53 DUKE L.J. 597, 609–12 (2003).
15. See id.
16. Robert B. Friedland, How Medicare Works, 29 GENERATIONS 1, 30 (2005).
17. Id.
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purchaser and third-party plans, as well as those between the plans
and their individual beneficiaries, revolve around the crucially
important but loosely defined concept of “medical necessity.”18
Medical necessity is a term of art in the health insurance industry that
may be used to determine whether insurance will cover an
intervention for an individual patient.19 All purchasers of health
benefits, including federal and state governments, Employee
Retirement Income Security Act (ERISA) covered health plans,
smaller firms that purchase health benefits for employees in the
commercial insurance market, and the small minority of citizens who
purchase individual policies from private health plans, enter into
contracts that legally entitle each member to all medically necessary
services.20 Since working definitions of medical necessity remain
vague, typically referring to generally accepted practice standards or
to services deemed necessary by a qualified physician or other health
care provider, risk-bearing payers face essentially unlimited exposure
to utilization and costs, which are largely at the discretion of
providers reimbursed on a fee-for-service basis that incentivizes
maximal utilization of all types of health services.21
Existing contracts deploy medical necessity as a binary or
dichotomous variable: for any given patient under a particular
clinical circumstance, each service is either “medically necessary” or
unnecessary, without any acknowledged middle ground to reflect
variability and uncertainty in the expected benefits, costs and harms
18. See generally Mark A. Hall & Gerard F. Anderson, Health Insurers’ Assessment of
Medical Necessity, 140 U. PA. L. REV. 1637, 1637–51 (1992) (discussing insurers’ use of medical
necessity in determining payment for health care services).
19. See id. at 1663–65 (describing a trend among insurers, since the mid-1970s, to control
costs by scrutinizing medical necessity).
20. 15 AM. JUR. 3D Proof of Facts § 355 (1992).
21.
[T]he excess baggage of “medical necessity” is not its pejorative connotation, but
rather its multiplicity of meanings. In today’s health care system, parties with a range
of backgrounds and biases are involved in medical necessity decisions. To many
physicians, the phrase “not medically necessary” means “not clinically indicated,”
which makes them question why a seemingly nonprofessional party such as a health
plan has the right to challenge their professional opinion. To many health plans, it
means “not covered even though not expressly excluded from coverage,” which gives
them a degree of comfort issuing denials based on established insurance practice even
though such decisions outrage physicians. Consequently, decisions involving medical
necessity are frequently characterized by inconsistent administration, poor
communication, distrust and, if disputes arise, relatively unprincipled, results-oriented
judicial resolution.
Sage, supra note 14, at 601.
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of diagnostic tests or treatments.22 Indeed, providers function under a
de facto presumption of medical necessity for the services they
render to patients, only rarely facing challenges on the need for
services either before or after they were rendered.23 During the
1990s, payer organizations tried to control costs by engaging in
detailed prospective case review and mandatory precertification for
elective surgical and diagnostic procedures.24 This brief experiment
failed following a political backlash from both consumers and
providers contending undue interference by financially motivated
third parties in the doctor-patient relationship.25 With few exceptions,
payers have now retreated from attempts to second-guess front-line
providers on the medical necessity of procedures they perform,
unleashing yet another round of steady increases in the volume of
complex imaging procedures, elective surgeries, and overall health
care costs.26
Viewed from a clinical perspective, the insurance industry’s
construction of medical necessity as a dichotomous variable bears
little resemblance to the realities of medical decision-making and
practice. Although financially it stacks the deck dramatically in favor
of providers, who can justify nearly any intervention under the
tautological principle that any procedure frequently performed by
licensed physicians is medically necessary because it represents
“standard practice.”27 In clinical settings, the medical necessity or
appropriateness of any given test or treatment for a particular patient
22. See, e.g., Medically Necessary/Medical Necessity, HEALTHPARTNERS (2013), http://
www.healthpartners.com/public/coverage-criteria/medically-necessary; Shield Savings and
Spectrum PPO Savings Plan, BLUE SHIELD OF CALIFORNIA LIFE AND HEALTH INSURANCE
COMPANY (2013), https://www.blueshieldca.com/producer/documentlibrary/A16490-8_7-9.pdf
(discussing plan coverage of services that are deemed medically necessary).
23. Timothy P. Blanchard, “Medical Necessity” Determinations—A Continuing Healthcare
Policy Problem, 37 J. HEALTH L. 599, 618–19 (2004).
24. James C. Robinson, The End of Managed Care, 285 JAMA, 2622, 2622–23 (2001).
25. Id.
26. Id.
27. Furthermore, additional deference may be given to the opinion of a treating physician, as
the party presumably most familiar with an individual patient’s clinical needs. “The ‘treating
physician rule’, as adopted by some courts, dictates that the treating physician’s determination
that a service is medically necessary is binding unless contradicted by substantial evidence, and is
entitled to some extra weight, even if contradicted by substantial evidence, because the treating
physician is inherently more familiar with the patient’s medical condition.” Andrew B. Wachler,
The New Audit Landscape: MICs, MACs, and RACs (Medicaid Integrity Contractors, Medicare
Administrative Contractors, and Recovery Audit Contractors), AMERICAN HEALTH LAWYERS
ASSOCIATION, http://www.healthlawyers.org/Events/Programs/Materials/Documents/HHs10
/wachler.pdf (citations omitted) (last visited Feb. 20, 2014).

REDEFINING MEDICAL NECESSITY

950

REDEFINING MEDICAL NECESSITY

10/26/2014 10:51 AM

[Vol. 47:943

depends on a complex set of clinical circumstances, and rarely
reflects a simple dichotomous or binary judgment.28 Instead,
depending in part on individual patient circumstances, any given
intervention falls somewhere between the following categories:
(a) unequivocally necessary; (b) desirable on balance but not entirely
necessary; (c) unnecessary because expected benefits to the patient
do not justify the costs, time, or risk; or (d) unnecessary and
contraindicated due to the greater likelihood of net harm to the
patient. While these determinations are made routinely by practicing
clinicians based on their training, personal experience, and implicit
judgment, a well-developed scientific approach also exists for the
quantitative assessment of medical necessity. Thus, a more nuanced
approach to judging the need for procedures is feasible, and the
requisite methodology has been broadly applied and described in
detail in the peer-reviewed medical literature.
Beginning in the early 1980s, Robert Brook led a group of
health services researchers at RAND in an ambitious scientific
initiative to quantitatively determine the medical necessity of
commonly performed elective diagnostic and therapeutic
procedures.29 These researchers used explicit methods that combined
published evidence from the peer-reviewed medical literature with

28. Marc A. Koopmanschap et. al., Dear Policy Maker: Have You Made Up Your Mind? A
Discrete Choice Experiment Among Policy Makers and Other Health Professionals, 26:2 INT’L J.
TECH. ASSESSMENT IN HEALTH CARE 198, 203–04 (2010); see also, Linda A. Bergthold, Medical
Necessity: Do We Need It? 14 HEALTH AFFAIRS, 180–81 (1998) (tracing the history and use of
the term “medical necessity”).
29. The RAND/UCLA Appropriateness Method (RAM) is “only one of several methods that
have been developed to identify the collective opinion of experts.” KATHRYN FITCH ET AL., THE
RAND/UCLA APPROPRIATENESS METHOD USER’S MANUAL (2001), http://www.rand.org
/content/dam/rand/pubs/monograph_reports/2011/MR1269.pdf. The RAM
was developed in the mid-1980s, as part of the RAND Corporation/University of
California Los Angeles (UCLA) Health Services Utilization Study, primarily as an
instrument to enable the measurement of the overuse and underuse of medical and
surgical procedures. In the RAM, the concept of appropriateness refers to the relative
weight of the benefits and harms of a medical or surgical intervention. An appropriate
procedure is one in which ‘the expected health benefit (e.g., increased life expectancy,
relief of pain, reduction in anxiety, improved functional capacity) exceeds the expected
negative consequences (e.g., mortality, morbidity, anxiety, pain, time lost from work)
by a sufficiently wide margin that the procedure is worth doing, exclusive of cost[.]’
Robert H. Brook, who identified the need for a tool to measure the appropriateness of
care, explained that ‘it was motivated by the concern that the increasing complexity of
medical care was resulting in some patients not undergoing procedures that they
needed, and others undergoing procedures that they did not need[.]’
Id. at 1 (internal quotation marks and citations omitted).

REDEFINING MEDICAL NECESSITY

2014]

REDEFINING MEDICAL NECESSITY

10/26/2014 10:51 AM

951

the balanced judgment of multi-disciplinary expert clinician panels in
a nominal group process that limited the impact of any individual
panel member on final results.30 Using a multi-round modified
Delphi method,31 panelists rated the medical necessity of each
procedure in hundreds of individual, detailed clinical scenarios using
a nine-point Likert scale.32 A rating of one on the Likert scale
indicated a clinical circumstance in which the procedure was deemed
both unnecessary and inappropriate, a five reflected an equivocal
rating, and a nine anchored the upper end of the scale, denoting a
clinical scenario in which panelists deemed the intervention in
question to be both appropriate and necessary.33 Of note, panelists
were explicitly instructed to ignore monetary costs in their judgments
of medical necessity and adhere to a strict definition deeming a
procedure necessary to the extent that its expected medical benefits
sufficiently exceeded the likely medical risks to make the procedure
worthwhile.34 These methods developed at RAND were later adopted
by other academic institutions, private firms, and publicly funded
delivery systems in Europe to more precisely assess the necessity of
specific procedures based on detailed clinical scenarios.35
The quantitative construction of medical necessity combining
published evidence with expert consensus invented at RAND holds
that medical necessity represents a multi-level, ordinal variable,
anchored on the high end by life-saving procedures such as
appendectomy for acute appendicitis or immediate surgery to control
hemorrhage resulting from trauma, and on the low end by any
30. Id.
31. The “Delphi method” was developed at RAND in the 1950s as a tool to predict the
future, and it has come to be used in a variety of health and medical settings. “The method
generally involves multiple rounds, in which a questionnaire is sent to a group of experts who
answer the questions anonymously. The results of the survey are then tabulated and reported back
to the group, and each person is asked to answer the questionnaire again. This iterative process
continues until there is a convergence of opinion on the subject or no further substantial changes
in the replies are elicited.” Id.
32. “A Likert scale is an ordered scale from which respondents choose one option that best
aligns with their view. It is often used to measure respondents’ attitudes by asking the extent to
which they agree or disagree with a particular question or statement. A typical scale might be
‘Strongly disagree, Disagree, Neutral, Agree, Strongly agree.’” Jan Losby & Anne Wemore, CDC
Coffee Break: Using Likert Scales in Evaluation Survey Work, NAT’L CENTER FOR CHRONIC
DISEASE PREVENTION AND HEALTH PROMOTION (2013), http://www.cdc.gov/dhdsp/pubs/docs
/CB_February_14_2012.pdf.
33. Fitch, supra note 29.
34. Id. at 4.
35. See generally id.
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procedures whose medical risks outweigh their benefits, including
entirely elective surgical interventions for cosmetic or lifestyle
enhancement.36 Between these two extremes, the RAND method
recognizes intermediate levels of necessity that balance the likely
benefits of a procedure against its possible harms, as well as the
comparative benefits of alternative, less invasive interventions.37
While methodologically demanding to produce and deploy, this
multi-level conception of medical necessity reflects much more
closely the approach applied daily by practicing physicians than does
the dichotomous model enshrined in existing contracts between
payers and health plans on the one hand, and between health plans
and their members on the other. Some examples will help illustrate
how this more nuanced conception of medical necessity works in
practice.38 The RAND method was applied to hysterectomy, the
surgical removal of the uterus (and often the ovaries), a common
procedure performed for a variety of indications and complaints.39
The expert panels charged with determining the clinical
circumstances under which hysterectomy is medically necessary
focused their attention on indications where the surgery might yield
symptomatic improvement, but also entails significant risks and
represents one of a range of alternative treatment options (such as
medical management or less invasive surgical interventions).40 The
panel deemed hysterectomy performed to treat gynecologic cancer to
be unequivocally necessary and was not included in this study.41
36. See generally id.
37. Id. at 2.
38.
Many procedures have been the subject of appropriateness studies in the United States,
among them, coronary angiography, coronary artery bypass graft surgery, percutaneous
transluminal coronary angioplasty, carotid endarterectomy, abdominal aortic aneurysm
surgery, diagnostic upper gastrointestinal endoscopy, cataract surgery, colonoscopy,
cholecystectomy, hysterectomy, tympanostomy and spinal manipulation for lower back
pain. The method has since been applied to some of these as well as other conditions
and procedures—benign prostatic hyperplasia, laminectomy, breast cancer and total
hip replacement—in a wide variety of countries, including Canada, Israel, Italy, The
Netherlands, Spain, Sweden, Switzerland, and the United Kingdom. Use continues to
expand to other countries, particularly in Western Europe.
Id. at 2 (internal citations omitted).
39. Michael S. Broder, et al., The Appropriateness of Recommendations for Hysterectomy,
95 OBSTET GYNECOL 199, 199–205 (2000), http://media.redding.com/media/static/The
_Appropriateness_of_Recommendations_for.7.pdf.
40. Id. at 200.
41. Id. at 202.
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Instead, the experts focused their attention on the most common
indications for elective hysterectomy such as abnormal uterine
bleeding and pelvic pain.42 For these indications, the panelists rated
the medical necessity on the nine-point scale, based on balancing the
expected benefits against the likely risks of surgery, as well as the
availability of effective nonsurgical alternatives.43
For example, a forty-two-year-old woman proposed for a
hysterectomy to control abnormal uterine bleeding, who had not
received a trial of hormonal treatment or more limited surgeries such
as dilation and curettage44 and whose daily functioning was not
dramatically impacted by her bleeding symptoms, received low
medical necessity ratings in the one to three range, because of the
availability of less invasive alternative treatments that often yield
acceptable outcomes in these circumstances.45 In contrast, if the
same patient had failed the trial of hormonal treatment, did not
respond to less invasive procedures, and was frequently limited in
her daily activities due to bleeding or required multiple transfusions
to replace blood loss, hysterectomy received high necessity ratings in
the seven to nine range.46 In other words, by combining evidence
from published outcomes studies with multidisciplinary expert
opinion, the RAND researchers were able to define a range of
necessity for a common procedure based on the detailed clinical
circumstances under which it was undertaken.47
To illustrate, an excerpt of the Matrix48 for evaluating
hysterectomy (here only in a subset of patients with cervical
dysplasia) is listed, along with an interpretation guide.49

42. Id. at 200–03.
43. Id. at 200.
44. Dilation and Curettage: Frequently Asked Questions, THE AM. C. OF OBSTETRICIANS
AND GYNECOLOGISTS (2012), http://www.acog.org/~/media/For%20Patients/faq062.pdf?dmc
=1&ts=20131219T0414505549. “D&C [dilation and curettage] is a surgical procedure in which
the cervix is opened (dilated) and a thin instrument is inserted into the uterus. This instrument is
used to remove tissue from the inside of the uterus (curettage) . . . D&C is used to diagnose and
treat many conditions that affect the uterus, such as abnormal bleeding.” Id.
45. Broder et al., supra note 39, at 202.
46. Id.
47. Id. at 201–03.
48. STEVEN J. BERNSTEIN, RAND, S. CAL. HEALTH RESEARCH CONSORTIUM,
HYSTERECTOMY RATINGS OF APPROPRIATENESS 9 (1997).
49. Id. at 12.
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Hysterectomy is Indicated In Patients with
Cervical Dysplasia Who State They:
PREFER UTERINE PRESERVATION

Degree of Dysplasia
CIN I or II

955
Degree of
Dysplasia
CIN III/CIS

9
12345789
(1.0, 0.0, A)

9
12345789
(1.0, 0.0, A)

9
123456789
(1.0, 0.0, A)
9
123456789
(1.0, 0.0, A)

8 1
123456789
(1.0, 0.2, A)
621
123456789
(1.0, 0.4, A)

9
123456789
(1.0, 0.0, A)
9
123456789
(1.0, 0.0, A)

81
123456789
(1.0, 0.1, A)
72
123456789
(1.0, 0.2, A)

53
123456789
(1.0, 0.4, A)
63
123456789
(1.0, 0.3, A)

2311
1
123456789
(2.0, 1.4, A)
2222
1
123456789
(3.0, 1.4, I)

4311
123456789
(2.0, 0.8, A)
4311
123456789
(2.0, 0.8, A)

133
11
123456789
(3.0, 1.6, A)
1141
11
123456789
(3.0, 1.4, I)

81
123456789
(1.0, 0.1, A)
81
123456789
(1.0, 0.1, A)

81
123456789
(1.0, 0.1, A)
8 1
123456789
(1.0, 0.2, A)

432
123456789
(2.0, 0.7, A)

1142
1
123456789
(3.0, 1.1, I)

DO NOT PREFER UTERINE PRESERVATION, ARE <40
YEARS OLD AND HAVE:

No prior conization or excision:
No Children

Children
One prior conization or exision performed with
clear margins of resection:
No Recurrence
No Children

Children
Recurrence 2 or more years after conservative
procedure
No Children

Children
Recurrence < 2 years after conservative
procedure
No Children

Children
One prior conization or excision performed with
margins of resection showing dysplasia
No repeat sampling or no dysplasia on repeat
sampling
No Children

Children
Repeat sampling shows dysplasia
No Children
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333
123456789
(2.0, 0.7, A)

11321
1
123456789
(3.0, 1.3, I)

81
123456789
(1.0, 0.1, A)
9
123456789
(1.0, 0.0, A)

72
123456789
(1.0, 0.2, A)
81
123456789
(1.0, 0.1, A)

432
123456789
(2.0, 0.7, A)
333
123456789
(2.0, 0.7, A)

321 111
123456789
(4.0, 1.8, D)
132 1 2
123456789
(5.0, 1.6, I)

3231
123456789
(2.0, 0.9, A)
2331
123456789
(2.0, 0.9, A)

132 1 2
123456789
(5.0, 1.7, I)
13111 2
123456789
(5.0, 1.8, I)

621
123456789
(1.0, 0.4, A)
621
123456789
(1.0, 0.4, A)

422
1
123456789
(2.0, 1.3, A)
413
1
123456789
(2.0, 1.4, A)

3312
123456789
(2.0, 0.9, A)
3321
123456789
(2.0, 0.8, A)

11 111112
123456789
(6.0, 2.3, I)
11 12 112
123456789
(5.0, 2.3, I)

9
123456789
(1.0, 0.0, A)

71
1
123456789
(1.0, 0.6, A)

Two or more prior conizations or excisions
performed with clear margins of resection on
last procedure
No recurrence
No Children

Children
Recurrence 2 or more years after conservative
procedure
No Children

Children
Recurrence < 2 years after conservative
procedure
No Children

Children
More than one prior conization or excision with
margins of resection showing dysplasia
No repeat sampling or no dysplasia on repeat
sampling
No Children

Children
Repeat sampling shows dysplasia
No Children

Children
DO NOT PREFER UTERINE PRESERVATION, ARE 40
YEARS OR OLDER, AND HAVE:

No prior conization or excision
One prior conization or excision performed with
clear margins of resection
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No recurrence
Recurrence 2 or more years after conservative
procedure
Recurrence < 2 years after conservative
procedure

957

9
123456789
(1.0, 0.0, A)
54
123456789
(1.0, 0.4, A)
423
123456789
(2.0, 0.8, A)

9
123456789
(1.0, 0.0, A)
215
1
123456789
(3.0, 1.2, A)
11311 1 1
123456789
(3.0, 1.8, I)

81
123456789
(1.0, 0.1, A)
324
123456789
(2.0, 0.8, A)

8 1
123456789
(1.0, 0.2, A)
111221
1
123456789
(4.0, 1.7, I)

81
123456789
(1.0, 0.1, A)
4 5
123456789
(3.0, 0.9, A)
314 1
123456789
(3.0, 1.0, A)

8
1
123456789
(1.0, 0.3, A)
1 2111111
123456789
(5.0, 2.1, D)
2211 21
123456789
(5.0, 1.9, I)

7 2
123456789
(1.0, 0.4, A)
31311
123456789
(3.0, 1.1, A)

6 1 2
123456789
(1.0, 1.1, A)
1
212 21
123456789
(6.0, 1.9, I)

One Prior conization or excision performed with
margins of resection showing dysplasia
No repeat sampling or no dysplasia on repeat
sampling
Repeat sampling shows dysplasia
Two or more prior conizations or excisions
performed with clear margins of resection on
last procedure
No recurrence
Recurrence 2 or more years after conservative
procedure
Recurrence < 2 years after conservative
procedure
More than one prior conization or excision with
margins of resection showing dysplasia
No repeat sampling or no dysplasia on repeat
sampling
Repeat sampling shows dysplasia

The use of advanced imaging in the setting of low back pain
offers another example of the same principle. Acute low back pain
represents one of the most common indications for patients to seek
medical care in the United States.50 The vast majority of these
episodes resolve within a few days to weeks without specific
treatment beyond short-term symptom control with appropriate
analgesics.51 Some of these episodes result from specific anatomic
50. See Steven J. Atlas & Richard A. Deyo, Evaluating and Managing Acute Low Back Pain
in the Primary Care Setting, 16 J. GEN. INTERNAL MED. 120, 120 (2001) available at
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1495170/pdf/jgi_91141.pdf.
51. Barbara S. Webster et al., Iatrogenic Consequences of Early Magnetic Resonance
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derangements such as lumbar disc herniation, but even these
episodes resolve without surgical intervention in approximately 60 to
70 percent of cases.52 Despite this, patients presenting with low back
pain often receive advanced imaging, such as magnetic resonance
imaging (MRI), early in the course of their illness.
These imaging tests may reveal abnormalities, such as disc
herniations, that arouse concern for both patient and practitioner
despite the well-documented fact that herniated disc symptoms,
while initially severe, generally improve rapidly with non-operative
measures and most often resolve spontaneously in the course of a
few weeks.53 The presence of the radiographic abnormality, in
combination with severe symptoms, often leads to unnecessary lower
back surgery.54 Applying the RAND approach, a patient with acute
low back pain, even with features strongly suggestive of lumbar disc
herniation, such as radiation of pain to the lower extremity, would
receive a low rating of medical necessity for MRI early in the course
of the illness in the absence of signs of serious neurologic
compromise.55 However, following a trial of conservative treatment,
which might include physical therapy and other non-operative
treatments, if this same patient remained limited by back and leg pain
after several weeks then imaging could be used to determine the
likely benefit from disc surgery. This would move the determination
of medical necessity toward the high end of the scale, since the
failure of symptoms to resolve with non-operative measures on
balance favors surgical intervention for patients who desire more
rapid relief of symptoms.56 Moving from a binary or dichotomous
definition of medical necessity to a more nuanced, multi-level rating
based on detailed clinical circumstances offers a number of
intriguing possibilities for reducing unnecessary care and controlling
Imaging in Acute, Work-Related, Disabling Low Back Pain, 32 SPINE 1939 (2013) (“Early MRI
without indication has a strong iatrogenic effect in acute LBP, regardless of radiculopathy status.
Providers and patients should be made aware that when early MRI is not indicated, it provides no
benefits, and worse outcomes are likely.”).
52. Alessandra Splendiani et. al., Spontaneous Resolution of Lumbar Disk Herniation:
Predictive Signs for Prognostic Evaluation, 46 NEURORADIOLOGY 916, 919 (2004).
53. Id.
54. Derek J. Emery et al., Overuse of Magnetic Resonance Imaging, 173 JAMA INTERNAL
MED. 823, 824 (2013) (finding “evidence of substantial overuse of lumbar spine MRI scans”
where “[o]ver half the requests (55.7%) were inappropriate (28.5%) or of uncertain value
(27.2%)”).
55. See id. at 823–24.
56. Id.
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costs.57 At the same time, this multi-level rating system can improve
value from both the patient’s and the payer’s perspectives.58
Validated multi-level ratings of medical necessity, based on clinical
circumstances for a majority of commonly performed and costly
diagnostic and therapeutic procedures, could be deployed in a variety
of ways to ensure that patients who stand to substantially benefit
retain access to these procedures59 while those who might benefit
more from alternative and less complex interventions are offered
both an opportunity and an incentive to select them. Here, we
explore only one possible application of multi-level medical
necessity: varying the patient’s co-payment for the procedure based
on experts’ ratings of medical necessity under specific, detailed
clinical circumstances.
In the examples offered above, a woman desiring a
hysterectomy for bleeding prior to a trial of conservative treatment
would not be denied coverage based on a failure to meet a medical
necessity threshold. Instead, she might be offered the procedure with
a 30 to 40 percent co-pay prior to undergoing the surgery, perhaps
amounting to several thousand dollars. However, the same patient,
after failing an adequate trial of alternative non-operative treatments,
might receive the surgery with a low or even no co-pay since the
failure of alternative therapy increases the appropriateness of a
surgical intervention. In the low back pain example, a patient
desiring an MRI during the first week of his symptoms could be
offered the procedure with a 50 percent co-pay. Alternatively, should
he elect to delay the imaging and try non-operative treatments, but
remain symptomatic and disabled by his back and leg symptoms
after a period of six to eight weeks, he would receive imaging with a
nominal or no co-pay since the failure of symptoms to follow the
usual pattern of spontaneous resolution places the patient in a
different clinical category where the benefits of imaging and
decompressive surgery of a disc herniation begin to outweigh the
potential risks.
57. Anthony J. Culyer & Yvonne Bombard, An Equity Framework for Health Technology
Assessments, 32 MED. DECISION MAKING 428, 429 (2012) (“The framework is primarily intended
for high-level decision makers who specify the criteria to be used by HTA advisory
committees.”); see Sara Rosenbaum et al., Who Should Determine When Health Care Is
Medically Necessary?, 340 NEW ENG. J. MED. 229, 230 (1999).
58. Culyer & Bombard, supra note 57, at 429.
59. Id. at 429–31.
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Varying the co-payment to reflect the level of medical necessity
determined by published evidence and expert opinion has several
advantages. This variation retains an element of patient choice in
accessing complex or invasive treatments, while incentivizing
patients to try less invasive and costly alternatives in circumstances
where these treatments are likely to result in similar outcomes.
Properly executed by an impartial body, detailed medical necessity
criteria could serve as the basis for overcoming a principal cause of
market failure in the health care sector, namely the inability of the
typical consumer to judge on his or her own the relative merits of
different diagnostic and treatment approaches. It would provide
patients, as well as payers and providers, with expert input on the
comparative effectiveness of different treatment strategies.60 In
comparison to outright denials of service based on adverse medical
necessity decisions attempted by health plans during the 1990s,
which resulted in a public opinion backlash that scuttled the first
round of managed care reforms,61 the variable co-payment approach
may more closely reflect societal values favoring freedom of choice
among treatment options by individuals and their physicians,62 while
at the same time giving consumers access to evidence-based
guidance on the relative costs and advantages of the different
treatments available to them.
However, the variable co-pay approach proposed here has
several important limitations. Chief among these limitations is the
challenge of developing multi-level medical necessity ratings for
common or costly treatments based on an unbiased and broadly
representative interpretation of existing published data on the
comparative effectiveness of different treatments, using validated
methods to combine expert opinion with published evidence. The
RAND approach offers one example of how this can be
accomplished,63 and advances in information technology allowing
broader input from a larger, geographically dispersed panel of
experts would further enhance adaptation of these proven methods to
current circumstances.64 Strict avoidance of any conflict of interest
60.
61.
62.
(1998).
63.
64.

See sources cited supra note 57.
See Sage, supra note 14, at 609–12.
RJ Belndon et al., Understanding the Managed Care Backlash, 17 HEALTH AFF., 80, 81
See supra notes 27–34.
Referring to the importance of a varied panel of experts, the article states that “[t]he
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between those involved in developing medical necessity ratings and
entities applying them in variable co-payment contracts would be
critical to the ethical and sustainable implementation of this
approach.
Independent, non-profit organizations such as the PatientCentered Outcomes Research Institute (PCORI) and the Institute of
Medicine (IOM) may be the most appropriate parties to generate
Matrices of Appropriateness.65 While health insurance companies
could internally develop Matrices, their financial incentives to limit
spending on necessary as well as unnecessary care,66 and the public
perception that insurers do not always act in the best interests of their
enrollees,67 may limit the effectiveness of insurer-developed
Matrices. Alternately, a government agency, such as the Centers for
Medicare and Medicaid Services (CMS), might develop Matrices for
internal use or to disseminate for use by private insurers.
Government agencies would have the advantage of being missiondriven to benefit the public but the disadvantage of being potentially
captive to political interests.68 Political interests have already been a
significant barrier, for example, to government initiatives in the
Affordable Care Act (ACA) designed to promote comparative
effectiveness research (CER), resulting in
[m]any Republicans, private institutions, and conservative
pundits [going] into “rhetorical overdrive,” with claims of
government interference in patient care and rationing of
services. Town hall meetings resonated with concerns over
decision as to which specialty or specialties to include will depend on the particular procedure
under study and the way clinical decisions are made in each country,” followed by a discussion of
different approaches employed in the United States, Sweden, Spain, Switzerland, and the
Netherlands. Fitch, supra note 29, at 23.
65. Patient-Centered Outcomes Research, PATIENT-CENTERED OUTCOMES RES. INST.,
http://www.pcori.org/research-we-support/pcor/ (last updated Nov. 7, 2013); see Our Study
Process, INSTITUTE OF MEDICINE, http://www.iom.edu/About-IOM/Study-Process.aspx (last
updated June 26, 2012).
66. See Containing Health Care Costs, THE MERCK MANUAL, http://www
.merckmanuals.com/professional/special_subjects/financial_issues_in_health_care/containing
_health_care_costs.html (last updated Oct. 2013) (stating that “[i]nsurance companies have
limited access to care by denying coverage to people likely to need care”).
67. See Tanzina Vega, Insurers Seek to Soften Their Image, No Matter How Court Rules on
Health Act, N.Y. TIMES, June 22, 2012, at A14 (quoting Harvard Business School professor
Regina E. Herzlinger as stating that insurance providers “are among the most disliked industries
in the United States”).
68. Ryan Abbott, Big Data and Pharmacovigilance: Using Health Information Exchanges to
Revolutionize Drug Safety, 99 IOWA L. REV. 225, 257 (2013).
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the creation of “death panels” and fear that the United
States would adopt a “British-style” model of health care.69
Efforts by government agencies to limit unnecessary care have also
failed in the past. One of the highest profile historical examples
occurred when the Agency for Health Care Policy and Research
(AHCPR), which was created in 1989 to carry out outcomes studies,
develop practice guidelines, and conduct and coordinate health
services research, was criticized by the North American Spine
Society (NASS) (an association of back surgeons), with the support
of a number of Republican politicians, after the AHCPR reported
that “there was no evidence to support spinal-fusion surgery and that
such surgery commonly had complications.”70 The agency ultimately
survived the incident, but with a new name that removed the word
“policy”: the Agency for Healthcare Research and Quality
(AHRQ).71 The incident also resulted in the abandonment of the
agency’s practice guideline program and a 21 percent budget cut.72
Regardless of what party develops Matrices of Appropriateness,
private health insurance companies utilizing Matrices would gain a
competitive advantage from being able to minimize spending on
unnecessary care, which would provide a market-driven impetus to
adopt a multi-level medical necessity rating system. As a general
matter, medical necessity is defined in insurance contracts, and
judicial interpretation of the language in policies is governed by the
rules established for the construction and interpretation of written
contracts generally.73 Some state laws specify a standard definition
of medical necessity that health plans are required to use, but these
states are in the minority.74 Other states have general legislation that
might impact plans’ definitions of medical necessity75 even though
there is no state-mandated definition, while yet a third set of states

69. Corinna Sorenson et al., The Politics of Comparative Effectiveness Research: Lessons
from Recent History, 39.1 J. HEALTH POL. POL’Y & L. 139, 140 (2014) (internal citation omitted).
70. Id. at 147–48 (internal citation and quotation marks omitted).
71. Id. at 149.
72. Id.
73. 15 AM. JUR. 3D, supra note 20, § 355.
74. CENTER FOR HEALTH POLICY, STANFORD UNIVERSITY, STATE-BY-STATE COMPENDIUM
OF MEDICAL NECESSITY REGULATION: SURVEY OF STATE MANAGED CARE REGULATORS 12
(2001), available at http://www.hcfo.org/files/hcfo/stanford.pdf. (indicating that 11 states have
any legislation that might impact plans’ definitions).
75. Id.
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have no legislation that might impact a definition.76 While a
state-by-state analysis is beyond the scope of this Article, insurers
should be free to adopt a multi-level definition in most markets. The
ACA does not define medical necessity.77
The ACA does, however, significantly strengthen the external
review process,78 and this represents an even stronger reason for
insurers to adopt an unbiased, third-party Matrix of Appropriateness
when making medical necessity determinations. The ACA
establishes a set of rules for consumers to appeal a health insurance
plan directly with the insurer (an internal appeal), as well as a right to
have an independent review organization decide whether to uphold
or overturn the plan’s decision (an external review).79 The
conventional wisdom about external, or judicial, reviewers is that
they tend to promote access to sympathetic patients.80 However,
determinations adverse to insurers would probably be less likely
when an insurer could demonstrate a medical necessity determination
was made on the basis of an independently generated, non-biased,
and evidence-based Matrix. The ACA also limits the upper bound of
patient cost sharing; out-of-pocket limits for health plans are
approximately $6,350 in 2014.81
Unavoidably, variable co-pays for elective procedures would
disproportionately affect low-income individuals, necessitating
measures to balance the impact of co-pays according to each
patient’s ability to pay them. This balancing could be accomplished
through scaling co-pay amounts to a percentage of annual income.
Extreme caution would be needed when applying this approach to
potentially life-saving treatments for serious conditions such as
cancer, despite the fact that the same basic principles govern medical
76. Id.
77. Daniel Skinner, Defining Medical Necessity under the Patient Protection and Affordable
Care Act, 73 PUB. ADMIN. REV. S49, S50 (2013); see also Patient Protection and Affordable Care
Act of 2010, Pub. L. No. 111-148, 124 Stat. 119 (2010) (codified at various sections) (failing to
provide a definition for “medical necessity”).
78. See 42 U.S.C. § 300gg-19 (2014).
79. Id.; The Ctr. for Consumer Info. & Ins. Oversight, HHS-Administered Federal External
Review Process for Health Insurance Coverage, CENTERS FOR MEDICARE AND MEDICAID
SERVICES, http://www.cms.gov/CCIIO/Programs-and-Initiatives/Consumer-Support-and
-Information/csg-ext-appeals-facts.html (last visited Jan. 26, 2014).
80. Sage, supra note 14, at 610–11.
81. Focus on Health Reform: Patient Cost-Sharing Under the Affordable Care Act, THE
HENRY J. KAISER FAM. FOUND. 1, 3 (2012), http://kaiserfamilyfoundation.files.wordpress.com
/2013/01/8303.pdf.
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necessity determinations in these circumstances. For example, before
high-dose chemotherapy followed by bone marrow transplant was
proven not to extend the lives of patients suffering from metastatic
breast cancer, many such procedures were performed. The
procedures were, at the time, deemed medically necessary by virtue
of the fact that practitioners were willing to undertake them and they
held some hope on biological grounds of extending life or even
curing the disease.82 Now, payers have stopped covering this costly
and risky treatment for disseminated breast cancer because it does
not meet current, dichotomous criteria for medical necessity, lacking
proof of benefit after multiple clinical trials.83
In many instances, however, similar clarity on the efficacy of
emerging treatments for life-threatening conditions is not yet
available, and it would be unethical to expose patients to high
co-pays in circumstances where the science is not yet sufficiently
clear to make a reasoned, balanced judgment of the relative risks and
benefits of alternative approaches. However, the technique could be
ethically applied to expand choice at the boundaries of current,
dichotomous guidelines for managing potentially fatal illnesses. For
example, the U.S. Preventive Services Task Force (USPSTF)
recently recommended CT screening for lung cancer in heavy
smokers between the ages of fifty-five and eighty.84 For patients with
a strong preference for screening outside of these age and risk
guidelines, variable co-pays could be offered to lower the cost of
access to this potentially life-saving screening test, as long as a
mechanism for balancing income disparities was in place.
In conclusion, applying proven scientific methods to create
detailed, multi-level ratings of medical necessity for the most
commonly performed elective procedures, as well as for costly
interventions with a variable likelihood of benefit, offers a strategy
for reining in the overuse of diagnostic and therapeutic technologies.
This strategy would improve the quality and value of medical care
while maintaining an element of patient and consumer choice that
balances preferences for alternative treatments with a willingness to
82. Sage, supra note 14, at 611.
83. Id.
84. Screening for Lung Cancer: U.S. Preventative Services Task Force Recommendation
Statement, U.S. PREVENTIVE SERVICES TASK FORCE, http://www.uspreventiveservicestaskforce
.org/uspstf13/lungcan/lungcanfinalrs.htm#summary (last updated Dec. 2013).
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share in their costs. Because this strategy would be deployed in the
insurance industry, which remains under the legal purview of each
state, a variety of models could be tested. The principal challenges
entailed by this approach include ensuring the objectivity and
avoiding conflicts of interest in the development of the necessity
ratings, and scaling co-pays to income to blunt a disproportionate
impact on choice among lower-income individuals. Enshrined in the
contracts that bind health plans and their members, as well as those
between purchasers and health plans, variable co-pays for elective
procedures based on objective, multi-level medical necessity ratings
could offer a powerful tool for improving value while controlling
costs.
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